Dermatitis, Atopic: all 1,443 studies

Page 1 of 15. Open to participants first (253), then studies with results posted, then the rest; newest registration first within each.

• A Study to Learn About the Study Medicine Abrocitinib in People With Severe Atopic Dermatitis Who Have Switched From Other TherapiesNot yet recruitingNCT07887867
• A Study of Lebrikizumab in Adults and Adolescents With Face and Neck Atopic DermatitisNot yet recruitingNCT07873801Phase 3
• AD Treatment Optimization With Ebglyss in Real-World Practice: A Multicenter Study of Patient-Centered OutcomesNot yet recruitingNCT07856134Phase 4
• Abrocitinib Dose Tapering in Patients With Atopic DermatitisNot yet recruitingNCT07848074Phase 4
• A Study of JYP0066 Cream in Mild-to-Moderate Atopic DermatitisNot yet recruitingNCT07843290Phase 2
• Oral Melatonin as Adjunctive Therapy in Adults With Atopic DermatitisNot yet recruitingNCT07842900Not applicable
• Abrocitinib Treatment of Atopic Dermatitis in Children 2 to Less Than 6 Years of AgeNot yet recruitingNCT07823595Phase 3
• Secondary Bacterial Infections and Nasal Colonization in Scabies and Atopic DermatitisNot yet recruitingNCT07813611
• PRA-216 Atopic Dermatitis Safety and Efficacy StudyNot yet recruitingNCT07810777Phase 2
• Changes in Skin Myco- and Microbiome After Lebrikizumab TreatmentRecruitingNCT07807228
• Skin-in-Sight: a Longitudinal Cohort Infrastructure for Standardized Remote Monitoring and the Evaluation of Digital Care Innovations in Chronic Skin DiseasesNot yet recruitingNCT07804134
• Phase 1 Study of QX-4533 in Healthy Volunteers and Patients With Moderate-to-Severe Atopic DermatitisRecruitingNCT07800104Phase 1
• A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Profiles of TLL-018 in Patients With Moderate-to-Severe Atopic DermatitisNot yet recruitingNCT07784816Phase 2/3
• A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to Severe EczemaRecruitingNCT07783425Phase 3
• Study of HXN6005 in Healthy Participants and Patients With Moderate-to-Severe Atopic DermatitisNot yet recruitingNCT07782476Phase 1/2
• A Study Evaluating TRIV-573 in Atopic DermatitisNot yet recruitingNCT07782333Phase 2
• Evaluation of 611 in Chinese Children With Moderate to Severe Atopic Dermatitis(AD)RecruitingNCT07767253Phase 3
• A Study to Learn About the Study Medicine Called Tilrekimig in People With Moderate-to-Severe EczemaRecruitingNCT07765888Phase 3
• Randomized, Double-blind, Placebo-controlled Study of Nemolizumab in Chinese Subjects With Moderate-to-severe Atopic DermatitisRecruitingNCT07762833Phase 3
• Use of Bifidobacterium Bifidum in Formula-Fed Infants With Colic, With or Without Atopic DermatitisRecruitingNCT07754968Not applicable
• A Study to Evaluate the Equivalence of IBI3027 and Dupilumab Injection in Participants With Moderate to Severe Atopic DermatitisRecruitingNCT07754786Phase 3
• An Observational Study of Patients With Dermatologic DiseaseNot yet recruitingNCT07748169
• A Study of BYN-001 in Healthy Adults and in Adults With Moderate to Severe Atopic DermatitisRecruitingNCT07746817Phase 1
• Digital Mindfulness Meditation in Adolescents With Atopic DermatitisRecruitingNCT07746427Not applicable
• Effectiveness of Upadacitinib and Biologics for the Achievement of Minimal Disease Activity in Adults With Moderate-to-Severe Atopic Dermatitis (RAMpUp)Not yet recruitingNCT07741838
• Long-term Safety and Efficacy Evaluation of IMG-007 in Participants With Moderate-to-Severe Atopic DermatitisEnrolling by invitationNCT07734415Phase 2
• Reflectance Confocal Microscopy Evaluation of Skin Structure of Patients With Atopic Dermatitis Under NemolizumabRecruitingNCT07730788
• Azithromycin in Atopic DermatitisNot yet recruitingNCT07713186Phase 4
• Efficacy and Tolerability of a Probiotic OintmentNot yet recruitingNCT07701447Not applicable
• A Clinical Study of HRS-8797 in Healthy ParticipantsNot yet recruitingNCT07698756Phase 1
• The Safety and Efficacy of Upadacitinib in Refractory Autoimmune Related Cholangitis and Atopic Dermatitis With Moderate to Severe ItchingNot yet recruitingNCT07678645Phase 2
• Opzelura Experience StudyNot yet recruitingNCT07661979Phase 4
• Global Healthcare Study on Atopic DermatitisRecruitingNCT07659756
• Evaluation of a Non-Invasive Device for Early Detection of Atopic Dermatitis FlaresRecruitingNCT07645820
• A Phase 2b Dose-Ranging Study to Evaluate the Efficacy and Safety of ENV-294 in Adults With Moderate-to-Severe Atopic DermatitisRecruitingNCT07643766Phase 2
• HL-300 Ointment in Patients With Mild-to-Moderate Atopic DermatitisRecruitingNCT07629778Phase 1/2
• Adjunctive Oral Iron Supplementation in Atopic DermatitisNot yet recruitingNCT07613190Not applicable
• A First-in-human Study to Investigate Single Doses of DCY636 in Healthy Volunteers and Multiple Doses in Participants With Moderate to Severe Atopic DermatitisRecruitingNCT07604324Phase 1
• A Phase 2b Study of the Effects of Camoteskimab in Adults With Moderate-to-Severe Atopic DermatitisRecruitingNCT07599813Phase 2
• A Multicenter, Randomized, Double-blind, Vehicle Controlled Phase II Clinical Study to Evaluate the Efficacy and Safety of VC005 Gel in Adult Subjects With Mild to Moderate Atopic DermatitisRecruitingNCT07598383Phase 2
• Phase III Clinical Study of VC005 in Adult and Adolescents With Mild to Moderate Atopic DermatitisRecruitingNCT07592585Phase 3
• Assessment of cfDNA-STING Axis as a Potential Pathological Marker in Atopic DermatitisRecruitingNCT07573735
• Obtaining Descriptive Classifications of Pruritus and Assessing Change in Pruritus Over Time in Atopic Dermatitis Patients Using Topical Roflumilast Cream.RecruitingNCT07560618Phase 4
• The ROOT Study: Scaling the 'Standard of Care Plus' Obstetric Nutrition Model to Optimize Maternal and Infant HealthNot yet recruitingNCT07559773Not applicable
• Efficacy and Safety of Switching to Ivarmacitinib in Patients With Moderate-to-Severe Atopic Dermatitis With Inadequate Response to Interleukin-4 Receptor Alpha(IL-4Rα) Inhibitors: A Prospective, Multicenter, Real-World StudyNot yet recruitingNCT07550452Not applicable
• A Study of IBI3033 in Moderate-to-Severe Atopic DermatitisNot yet recruitingNCT07549984Phase 1
• Sebum Metabolomics and Lipidomics for Clinical ApplicationsNot yet recruitingNCT07549828Not applicable
• A Dose Escalation Phase 1 Study of HXN5003 in Healthy ParticipantsNot yet recruitingNCT07549750Phase 1
• A Study of Stapokibart Injection in Patients With Atopic Dermatitis (AD)RecruitingNCT07544862
• A Phase III Study of MG-K10 in Adolescents With Moderate-to-Severe Atopic DermatitisNot yet recruitingNCT07540442Phase 3
• First-in-Human Trial to Assess REGN20423 in Healthy Adult Participants and Adult Participants With Atopic DermatitisRecruitingNCT07527923Phase 1
• Nigella Sativa Oil for Eczematous Otitis ExternaRecruitingNCT07525505Not applicable
• A Randomized Controlled Trial Comparing the Effectiveness and Safety of Topical Tacrolimus 0.03% Versus Crisaborole 2% in Patients With Mild to Moderate Atopic Dermatitis Over 8 WeeksNot yet recruitingNCT07519174Not applicable
• A Study on the Efficacy of 2% Cholesterol Cream in Atopic DermatitisEnrolling by invitationNCT07503197Not applicable
• A Study of SKB575 (HBM7575) Injection in Healthy Participants and Atopic Dermatitis ParticipantsRecruitingNCT07488065Phase 1
• The Impact of Salt Intake on Sodium in the Skin and Inflammatory Skin DiseaseRecruitingNCT07487831Phase 4
• A Study to Evaluate the Efficacy and Safety of MG-K10 in Participants Who Have Atopic DermatitisNot yet recruitingNCT07479615Phase 3
• The Impact of Dupilumab Treatment on Anxiety and Depression Symptoms in Patients With Moderate-to-Severe Atopic DermatitisRecruitingNCT07467564
• Study of S-4321 in Participants With an Autoimmune or Immune-mediated DiseaseRecruitingNCT07455578Phase 1
• Ph 1a/1b Single Ascending Dose and Multiple Ascending Dose Study of ARQ-234RecruitingNCT07453602Phase 1
• Atopic Dermatitis Treated With Dupilumab and JAK Inhibitors in Costa RicaNot yet recruitingNCT07448363
• The Impact of Dietary Salt on the Severity of EczemaRecruitingNCT07447063Phase 4
• A Clinical Study to Evaluate SM17 for Atopic DermatitisRecruitingNCT07445919Phase 2
• Intervention With Tralokinumab in Patients With Moderate-to-severe Atopic Dermatitis With Genital ImpactRecruitingNCT07444801
• Randomized, Blinded, Placebo-Controlled Evaluation of BioAmicus CompleteRecruitingNCT07444008Not applicable
• Study to Evaluate Soquelitinib in Participants With Moderate to Severe ADRecruitingNCT07441395Phase 2
• Efficacy of Crisaborole 2% Cream Versus Placebo in Mild to Moderate Atopic EczemaNot yet recruitingNCT07438509Phase 4
• Comparative Evaluation of the Safety and Effectiveness of Crisaborole Ointment (2%) Versus Tacrolimus Ointment (0.1%) for the Topical Treatment of Atopic DermatitisNot yet recruitingNCT07437534Phase 4
• Cross-Sectional Study for an Ocular Imaging-Based Predictive Model of Inflammatory Skin Diseases Grounded in Traditional Chinese MedicineNot yet recruitingNCT07434076
• A Proof-of-Concept Study of IBI3002 in Patients With Moderate to Severe Atopic DermatitisRecruitingNCT07399067Phase 2
• A Phase III Study of GS101 Injection to Dupixent®RecruitingNCT07386743Phase 3
• Study of ADSTEM Injection for Patients With Moderate to Severe Subacute and Chronic Atopic DermatitisNot yet recruitingNCT07377838Phase 3
• Comparative Study of Crisaborole vs. Tacrolimus in Atopic DermatitisNot yet recruitingNCT07367932Phase 4
• A Study to Compare the Pharmacokinetics, Pharmacodynamic, Immunogenicity, and Safety of CKD-706 With US-Dupixent®, and EU-Dupixent® in Healthy Adult Participants.RecruitingNCT07358156Phase 1
• Double-blind, Randomized, Non-inferiority Trial in Atopic Dermatitis: Comparison of Lipikar Balm and Relipid+ Balm in the Treatment of Mild to Moderate Atopic Dermatitis in Children and AdultsRecruitingNCT07358000Not applicable
• A Double-Blind, Randomized, Vehicle-Controlled Phase 2 Study to Assess the Efficacy and Safety of GX-03 in Adult Subjects With Moderate to Severe Atopic Dermatitis (Eczema)RecruitingNCT07355075Phase 2/3
• Utilization of a Microdevice for Psoriasis and Atopic DermatitisNot yet recruitingNCT07352566Phase 4
• LANDSCAPE: Demographics and Treatment Patterns of Patients With Immune-Mediated Inflammatory Skin Diseases in Italian Clinical PracticeNot yet recruitingNCT07336641
• Retention of Vernix Caseosa in Newborns for Primary Prevention of Atopic DermatitisRecruitingNCT07333378Not applicable
• A Study to Evaluate Efficacy and Safety of IBI356 in Participants With Moderate to Severe Atopic DermatitisRecruitingNCT07330934Phase 2
• Real-World Study on the Impact of Atopic Dermatitis From a Caregiver PerspectiveNot yet recruitingNCT07323394
• Birth Cohort: Development of IgE Autoantibodies in Newborns With (High Risk of) Atopic DermatitisRecruitingNCT07316465Not applicable
• Study of ENV-294 in Adults With Moderate-to-Severe Atopic DermatitisRecruitingNCT07298395Phase 2
• Evaluation of Efficacy and Safety of Oral Roflumilast for Treatment of Moderate to Severe Atopic Dermatitis in Patients Aged 12 Years and Older: A Pilot StudyRecruitingNCT07297602Phase 2
• URGO FilmoCream Eczema + Dermocorticoids in Atopic DermatitisNot yet recruitingNCT07295678Not applicable
• This Study is a Non-interventional Disease Registry of Adolescent and Adult Patients With Atopic Dermatitis Who Initiate or Switch Any Systemic TreatmentRecruitingNCT07290803
• Treatment of Moderate-to-Severe Atopic Dermatitis With Ivarmacitinib in Adolescents and AdultsNot yet recruitingNCT07276620Not applicable
• Moisturization and Skin Hydration StudyNot yet recruitingNCT07270965Not applicable
• Evaluating the Safety and Tolerability of Baricitinib in Patients With Job Syndrome With Lupus-Like Disease and/or Atopic DermatitisRecruitingNCT07262983Phase 1
• Effect of an Emollient Cream Containing a Milk Bioactive Peptide on Clinical Signs, Pruritus and Bacterial Colonization of Mild Atopic Dermatitis Skin Lesions in Pediatric PopulationRecruitingNCT07259343Not applicable
• PALLAS Laser for Skin DiseasesRecruitingNCT07250997Not applicable
• Treatment of Atopic Dermatitis and Alopecia Areata With Abrocitinib in Individuals With Down SyndromeRecruitingNCT07242638Phase 2
• A Study of BBT001 in Healthy Volunteers (HVs) and in Adult Patients With Moderate to Severe Atopic Dermatitis (AD)RecruitingNCT07239947Phase 1
• A Phase 1/1b Study to Evaluate Safety, Tolerability and Pharmacokinetics of ZL-1503 in Healthy Volunteers and Participants With Moderate to Severe Atopic DermatitisRecruitingNCT07235384Phase 1
• A Long-term Safety and Efficacy Study Evaluating CM512 in Atopic Dermatitis.RecruitingNCT07230483Phase 2
• Cutaneous Biomarkers in Atopic Eczema Using a Non-Invasive Micro-Suction Device in BabiesRecruitingNCT07228962
• A Long Term Extension Study to Evaluate the Safety and Efficacy of Afimkibart (RO7790121) in Participants With Atopic DermatitisRecruitingNCT07223697Phase 2
• A Study to Learn About Study Medicine Called PF-08049820 in People With EczemaRecruitingNCT07216027Phase 2
• CeraVe Effect on Restoring Skin Hydration as Maintenance Regimen in Subjects With Mild to Moderate Atopic DermatitisRecruitingNCT07204561Not applicable
• A Phase II Clinical Study Evaluating of ZL-82 Tablets in Atopic DermatitisRecruitingNCT07193589Phase 2

← Dermatitis, Atopic overview